Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Jack Kain, PharmD

Advertisement

Articles by Jack Kain, PharmD

Does the CDC’s Proposed Opioid Prescribing Guideline Fall Short on Drug Testing?

Does the CDC’s Proposed Opioid Prescribing Guideline Fall Short on Drug Testing?

ByJack Kain, PharmD
June 16th 2022

Although the CDC has put forth a strong effort to improve its opioid guidelines, many providers still feel that more can be done.

Advertisement

Latest Updated Articles

  • Does the CDC’s Proposed Opioid Prescribing Guideline Fall Short on Drug Testing?
    Does the CDC’s Proposed Opioid Prescribing Guideline Fall Short on Drug Testing?

    June 16th 2022



Advertisement
Advertisement

Trending on Oncology Nursing News

1

ASCO Releases First Living Guideline for Recurrent Ovarian Cancer Care

2

FDA Approves Rusfertide, First-in-Class Hepcidin Mimetic for Polycythemia Vera

3

Oncology Nurses' Guide to FDA-Approved Iberdomide: Q&A With Surbhi Sidana

4

FDA Approves BESREMi for Adults with Essential Thrombocythemia

5

Managing Toxicities in Advanced RCC: Insights From an Expert Panel

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us